🇺🇸 FDA
Patent

US 12150461

Nicotinamide adenine dinucleotide (NAD) compositions, methods of manufacturing thereof, and methods of use thereof

granted A61KA61K31/7084A61K47/02

Quick answer

US patent 12150461 (Nicotinamide adenine dinucleotide (NAD) compositions, methods of manufacturing thereof, and methods of use thereof) held by Sovida Solutions Ltd. expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sovida Solutions Ltd.
Grant date
Tue Nov 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/7084, A61K47/02, A61K47/10, A61K47/22